Lupus Erythematosus (Le)

Lupus Erythematosus (Le) is a chronic inflammatory disease of connective tissue that affects the skin and various internal organs (systemic lupus erythematosus (systemic LE, SLE)). The main symptoms of the disease are: the appearance of a red scaly rash on the face (mainly on the nose and cheeks), arthritis and progressive kidney damage. Often, the patient also experiences progressive inflammation of the heart muscle, lungs, and brain, resulting in scar tissue (fibrosis) forming at the site of inflammation.

When a person has a mild form of the disease, called discoid lupus erythematosus (discoid LE (DLE)), only the skin is affected.

Lupus erythematosus is an autoimmune disease; It is diagnosed by the presence of antibodies in a person’s blood, which are usually absent in healthy people. It is treated with corticosteroids or immunosuppressive (immune-suppressing) drugs.

Lupus Erythematosus (LE): Chronic inflammatory disease of connective tissue

Lupus Erythematosus, also known as Lupus Erythematosus (LE), is a chronic inflammatory connective tissue disease that can affect the skin and various internal organs. The main forms of lupus erythematosus are systemic lupus erythematosus (systemic LE, SLE) and discoid lupus erythematosus (discoid LE, DLE).

Systemic lupus erythematosus (SLE) is the most common and serious form of the disease. SLE affects various organs and systems of the body, including the skin, joints, kidneys, heart, lungs and brain. One of the characteristic symptoms of SLE is the appearance of a red, scaly rash on the face, especially around the nose and cheeks. Known as “moon face,” this condition is often called “butterfly” because of its shape. People with SLE also often experience arthritis, kidney inflammation, and scar tissue (fibrosis) in the affected organs.

Discoid lupus erythematosus (DLE) is a more limited form of the disease that affects only the skin. Patients with DLE develop red, scaly rashes on the skin that can be itchy and uncomfortable. Unlike SLE, DLE usually does not affect internal organs and has a better prognosis.

Lupus is an autoimmune disease, which means the body's immune system mistakenly attacks its own tissues and organs. The diagnosis of lupus erythematosus is usually made based on clinical manifestations, blood test results, and examination of the patient. People with lupus erythematosus often have antibodies, such as antinuclear antibodies (ANA), that are usually absent in healthy people.

Treatment for lupus erythematosus depends on the form and severity of the disease. The goals of treatment are to reduce inflammation, control symptoms, and prevent organ damage. Various medications may be used for this, including corticosteroids, immunosuppressive drugs, and anti-inflammatory drugs. It is important to individually select a treatment regimen and regularly monitor the patient’s condition.

Although lupus erythematosus is a chronic disease, modern diagnostic and treatment methods can significantly improve the prognosis and quality of life of patients. It is important to see your doctor regularly and follow their recommendations to effectively manage the disease.

In conclusion, lupus erythematosus is a chronic inflammatory disease of the connective tissue that can affect the skin and various internal organs. It can manifest as systemic lupus erythematosus (SLE) or discoid lupus erythematosus (DLE). Diagnosis is based on clinical manifestations and blood test results. Treatment includes the use of anti-inflammatory and immunosuppressive medications. Modern diagnostic and treatment methods help patients cope with symptoms and improve their quality of life.

Lupus erythematosus: little is said about it.

**Systemic lupus erythematosus** is one of the most common chronic inflammatory diseases in the practice of a rheumatologist, affecting mainly young people. It is believed that this disease affects mainly residents of northern countries, although cases of its development are also recorded in many southern countries with different climatic conditions. Tens of thousands of new cases of red and lupopathy are reported every year. According to modern concepts, in some cases of lupus erythematosus, especially in the early stages of the disease, such treatment may still be justified and even contribute to successful treatment results.